Atlas Trials

A Trial of SHR-1210 (an Anti-PD-1 Antibody) in Combination With Apatinib in Patients With Advanced TNBC

Clinical trial NCT03394287 · COMPLETED

Trial details

NCT number
NCT03394287
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2018-01-10
Primary completion
2019-12-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.